Your session is about to expire
← Back to Search
Peripheral Nerve Stimulation for Restless Legs Syndrome
Study Summary
This trial will test a new non-invasive treatment for restless legs syndrome (RLS). The study will compare the new treatment to a sham (fake) treatment, and will test how well the treatment works and how well tolerated it is.
- Restless Legs Syndrome
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many enrollees are participating in this experimental research?
"Yes, information on clinicaltrials.gov attests to the fact that this trial is currently enrolling participants. The venture was first posted on March 8th 2022 and has since been updated as recently as April 26th of the same year; it requires 40 patients across 2 separate hospitals or clinics."
May I partake in this clinical experiment?
"This clinical trial is actively seeking 40 people aged between 22 and 89 with a diagnosed case of restless legs syndrome. Eligibility criteria includes a score of 15+ on the International Restless Legs Syndrome Study Group Rating Scale in the week prior to study entry, moderate-severe RLS symptoms that interfered with sleep at least 3 nights/week during the month before entering the trial, primary RLS confined primarily to lower limbs/feet, agreement not to alter any medications known to influence RSL symptoms or make major lifestyle changes throughout the duration of this research project; as well as having access to appropriate electronic equipment for completing questionnaires and responding promptly"
Are applicants below the age of sixty eligible to join this experiment?
"This clinical trial seeks out individuals between the ages of 22 and 89."
Is this experiment actively soliciting participants?
"Evidenced by clinicaltrials.gov, this research endeavour is actively recruiting for participants and was initially posted on March 8th 2022; it has since been revised as of April 26th 2022."
What is the central purpose of this experiment?
"This two week study is designed to measure Actigraphy-Based Sleep Efficiency. Additionally, it will assess Polysomnography-Based Sleep Efficiency, International Restless Legs Syndrome Study Group Rating Scale scores and Patient Global Impressions of Improvement Responder Rate."
Share this study with friends
Copy Link
Messenger